日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapies

不明原因重症肝炎中的系统性T细胞活化和IFN-γ活性与噬血细胞性淋巴组织细胞增生症相似:对T细胞和IFN-γ靶向治疗的启示

Nguyen, Thinh H; Satwani, Prakash; Kumar, Deepak; Kapoor, Urvi; Malik, Sakshi; Prince, Chengyu; Montminy, Taylor; Smiley, Kristi; Martinez, Mercedes; Goldner, Dana; Marsh, Rebecca; Remotti, Helen E; Fazlollahi, Ladan; Rytting, Heather B; Romero, Rene; Chandrakasan, Shanmuganathan

Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma

胰腺导管腺癌中普遍存在针对磷酸化氨基酸的高滴度类别转换抗体反应。

Aguiar, Talita; Mashiko, Shunya; Asam, Kesava; Roy, Poulomi; Wang, Shikun; Frank, Katharina; Dietzel, Max; Schahadat, Luca G Z; Ausmeier, Mattea; Hertel, Andrea; Duan, Zhe Ran Susan; Aouizerat, Bradley; Genkinger, Jeanine M; Remotti, Helen; Zorn, Emmanuel

Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer

一项针对晚期胰腺癌的肿瘤内注射talimogene laherparepvec的I期研究

Runcie, Karie; Bracero, Yadriel; Samouha, Avishai; Manji, Gulam; Remotti, Helen E; Gonda, Tamas A; Saenger, Yvonne

A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery

一项针对局限性胰腺腺癌患者术前使用贝他尼醇进行副交感神经刺激的0期机会窗口研究

White, Ruth A; Mezzano-Robinson, Valeria; Shi, Qiongyu; Kuriakose, Nadine; Schrope, Beth; Kluger, Michael D; Sugahara, Kazuki; Chabot, John; Manji, Gulam; Oberstein, Paul; Remotti, Helen; Wang, Timothy C; Bates, Susan E

Claudin 18 immunohistochemistry in cholangiocarcinoma

胆管癌中 Claudin 18 免疫组化

Desai, Niyati; Ko, Huaibin M; Lee, Michael; Fazlollahi, Ladan; Moy, Ryan H; Yoon, Sam S; Remotti, Helen; Levy, Brynn; Turk, Andrew T; Lagana, Stephen M

Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate Conversion

长链非编码RNA维持胰腺癌细胞的特性并抵抗细胞命运转变。

Grygoryev, Dmytro; Lee, Seung-Won; Frankston, Connor Mitchell; Rakshe, Shauna; Berry, Mark; Hirano, Alex; Ekstrom, Taelor; Manalo, Elise; Tessier, Julien; Chow-Castro, Marilynn; Link, Jason; Keith, Dove; Sheppard, Brett C; Fei, Suzanne; Morgan, Terry; Remotti, Helen E; Yang, Wenli; Furth, Emma; Thakurela, Sudhir; Sears, Rosalie C; Kim, Jungsun

Multimodal mass spectrometry imaging identifies cell-type-specific metabolic and lipidomic variation in the mammalian liver.

多模态质谱成像技术可识别哺乳动物肝脏中细胞类型特异性的代谢和脂质组学变化

Tian Hua, Rajbhandari Presha, Tarolli Jay, Decker Aubrianna M, Neelakantan Taruna V, Angerer Tina, Zandkarimi Fereshteh, Remotti Helen, Frache Gilles, Winograd Nicholas, Stockwell Brent R

A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.

治疗靶向的TAZ-TEAD2通路通过ANLN和KIF23驱动肝细胞癌的生长

Saito Yoshinobu, Yin Dingzi, Kubota Naoto, Wang Xiaobo, Filliol Aveline, Remotti Helen, Nair Ajay, Fazlollahi Ladan, Hoshida Yujin, Tabas Ira, Wangensteen Kirk J, Schwabe Robert F

TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis

TAZ诱导的Cybb促进非酒精性脂肪性肝炎中的肝肿瘤形成

Wang, Xiaobo; Zeldin, Sharon; Shi, Hongxue; Zhu, Changyu; Saito, Yoshinobu; Corey, Kathleen E; Osganian, Stephanie A; Remotti, Helen E; Verna, Elizabeth C; Pajvani, Utpal B; Schwabe, Robert F; Tabas, Ira

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

新辅助放化疗会改变胰腺导管腺癌的免疫微环境

Gartrell, Robyn D; Enzler, Thomas; Kim, Pan S; Fullerton, Benjamin T; Fazlollahi, Ladan; Chen, Andrew X; Minns, Hanna E; Perni, Subha; Weisberg, Stuart P; Rizk, Emanuelle M; Wang, Samuel; Oh, Eun Jeong; Guo, Xinzheng V; Chiuzan, Codruta; Manji, Gulam A; Bates, Susan E; Chabot, John; Schrope, Beth; Kluger, Michael; Emond, Jean; Rabadán, Raul; Farber, Donna; Remotti, Helen E; Horowitz, David P; Saenger, Yvonne M